FDA NDC Directory · JSON-LD · Markdown

Vectibix

NDC 55513-956 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namepanitumumab
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA125147
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsPANITUMUMAB (400 mg/20mL)
Marketing started20061010
Package count2

External sources

Source: openFDA. Public-domain (CC0).